Cart
sales@molnova.com
TCID
CAS No. 30675-13-9
TCID( UCH-L3 Inhibitor )
Catalog No. M13979 CAS No. 30675-13-9
TCID is a selective ubiquitin C-terminal hydrolase-L3 (UCH-L3) inhibitor with IC50 of 0.6 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 53 | In Stock |
|
| 2MG | 31 | In Stock |
|
| 5MG | 49 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 215 | In Stock |
|
| 100MG | 279 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTCID
-
NoteResearch use only, not for human use.
-
Brief DescriptionTCID is a selective ubiquitin C-terminal hydrolase-L3 (UCH-L3) inhibitor with IC50 of 0.6 uM.
-
DescriptionTCID is a selective ubiquitin C-terminal hydrolase-L3 (UCH-L3) inhibitor with IC50 of 0.6 uM, displays >100-fold selectivity over UCH-L1; diminishes glycine transporter GlyT2 ubiquitination in brain stem and spinal cord primary neurons.
-
In Vitro——
-
In Vivo——
-
SynonymsUCH-L3 Inhibitor
-
PathwayProteasome/Ubiquitin
-
TargetDUB
-
RecptorUCH-L1|UCH-L3
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number30675-13-9
-
Formula Weight283.9
-
Molecular FormulaC9H2Cl4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 14.2 mg/mL (50 mM) （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESC1C(=O)C2=C(C1=O)C(=C(C(=C2Cl)Cl)Cl)Cl
-
Chemical Name4,5,6,7-Tetrachloro-1H-Indene-1,3(2H)-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liu Y, et al. Chem Biol. 2003 Sep;10(9):837-46.
2. de Juan-Sanz J, et al. PLoS One. 2013;8(3):e58863.
molnova catalog
related products
-
USP30 inhibitor 18
USP30 inhibitor 18 is a selective inhibitor of USP30 (IC50 = 0.02 μM). USP30 inhibitor 18 is able to accelerate mitophagy and increase protein ubiquitination.
-
USP1-IN-2
USP1-IN-2 is a potent USP1 inhibitor with potential anti-tumor activity for the study of cancer.
-
USP8-IN-2
USP8-IN-2 is a potent inhibitor of the deubiquitinating enzymes USP7 and USP8, with an IC50 of 4.0 μM against USP8D. USP8-IN-2 is a potential compound for the treatment of cancer and viral infections.
